Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Tuesday, September 29

2:15 PM - 2:25 PM ET

280 - Connectome-Informed Cognition-Sparing Stereotactic Brain Radiosurgery: Comparison of Cognitive Outcomes to Historical Controls
Speaker: Puett, Andrew, MD, PhD - UC San Diego Radiation Medicine and Applied Sciences, La Jolla, CA
2:15 PM - 2:25 PM ET

286 - First Implementation of an All-In-One Solution with Fully Automatic Workflow for Rectal Cancer Based on an Integrated CT-Linac
Speaker: Wang, Luqi - Peking University Third Hospital, Beijing
2:15 PM - 2:25 PM ET

292 - A Randomized, Phase II Clinical Trial of Stereotactic Body Radiation Therapy Or Conventionally Fractionated Concurrent Chemotherapy and Radiation Therapy Preoperatively for Pancreatic Adenocarcinoma, the SOFT Preop Study
Speaker: Hall, William, MD - Medical College of Wisconsin, Milwaukee, WI
2:15 PM - 2:25 PM ET

298 - Type I IFN Drives ILC2 to ILC1 Plasticity in Radiation-Induced Lung Injury
Speaker: Kim, Jaeho, MD - City of Hope, Glendale, CA
2:15 PM - 2:25 PM ET

304 - Glioblastoma Distant Recurrences Preferentially Occur Along White Matter Tracts Mapped Using Probabilistic Diffusion Tractography
Speaker: Gui, Chengcheng, MD - Johns Hopkins University School of Medicine, Baltimore, MD
2:15 PM - 2:25 PM ET

335 - AI as a Safety Net: Clinical and Dosimetric Impact of Intercepting Undetected Brain Metastases in SRS/SRT
Speaker: Kinz, Marvin, MS - Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA
2:15 PM - 3:30 PM ET

Advances in the Treatment of Brain Metastases
Speaker: Minniti, Giuseppe, MD, PhD - Università di Roma Sapienza, Roma, Lazio
2:15 PM - 3:30 PM ET

Advances in the Treatment of Brain Metastases
Speaker: Simon, Aaron, MD, PhD - UC Irvine Health, Orange, CA
2:15 PM - 3:30 PM ET

Imaging Biomarkers
Speaker: Kuang, Yu, PhD - University of South Florida Morsani College of Medicine, Tampa, FL
2:15 PM - 3:30 PM ET

Imaging Biomarkers
Speaker: Grassberger, Clemens, PhD - University of Washington Radiation Oncology, Seattle, Wa
2:15 PM - 2:25 PM ET

LBA 01 - TRIDENT: Phase 3 Trial of Tumor Treating Fields (TTFields) Therapy Concurrent with Temozolomide (TMZ) Radiochemotherapy Followed by Maintenance TMZ and TTFields for Newly Diagnosed Glioblastoma (ndGBM)
Speaker: Shi, Wenyin, MD, PhD - Thomas Jefferson University, Philadelphia, PA
2:15 PM - 3:15 PM ET

Musculoskeletal Tumors and Skeletomuscular Toxicities
Speaker: Mahase, Sean, MD - Ohio State University Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, Ohio